Fig. 2From: Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrenceA-B The comparison of immune-related scores (A) and infiltrating levels of 22 immune cell types (B) between GTF2I wild type group and GTF2I mutant group. C-D The comparison of PD-1, PD-L1, CTLA4 (C), and 18 immune checkpoints expression (D) between GTF2I wild type group and GTF2I mutant groupBack to article page